574 related articles for article (PubMed ID: 17531857)
1. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
3. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa.
Lombard Z; Dalton DL; Venter PA; Williams RC; Bornman L
Hum Immunol; 2006 Aug; 67(8):643-54. PubMed ID: 16916662
[TBL] [Abstract][Full Text] [Related]
5. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease.
Karinen H; Kärkkäinen P; Pihlajamäki J; Janatuinen E; Heikkinen M; Julkunen R; Kosma VM; Naukkarinen A; Laakso M
Scand J Gastroenterol; 2006 Feb; 41(2):191-9. PubMed ID: 16484124
[TBL] [Abstract][Full Text] [Related]
6. HLA DRB1*15-DPB1*05 haplotype: a susceptible gene marker for isocyanate-induced occupational asthma?
Kim SH; Oh HB; Lee KW; Shin ES; Kim CW; Hong CS; Nahm DH; Park HS
Allergy; 2006 Jul; 61(7):891-4. PubMed ID: 16792590
[TBL] [Abstract][Full Text] [Related]
7. HLA serological and class II genotyping in sarcoidosis patients in Japan.
Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
[TBL] [Abstract][Full Text] [Related]
8. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
9. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
10. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
Rudick RA; Lee JC; Simon J; Fisher E
Ann Neurol; 2006 Aug; 60(2):236-42. PubMed ID: 16786526
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-DR with progressive systemic sclerosis in Japanese.
Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of HLA class II genes in Miao and Yao nationalities of Southwest China.
Liu Y; Liu Z; Fu Y; Jia Z; Chen S; Xu A
Tissue Antigens; 2006 Feb; 67(2):157-9. PubMed ID: 16441488
[TBL] [Abstract][Full Text] [Related]
15. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
16. Primary Sjögren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes.
Guggenbuhl P; Jean S; Jego P; Grosbois B; Chalès G; Semana G; Lancien G; Veillard E; Pawlotsky Y; Perdriger A
J Rheumatol; 1998 May; 25(5):900-5. PubMed ID: 9598888
[TBL] [Abstract][Full Text] [Related]
17. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
[TBL] [Abstract][Full Text] [Related]
18. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C.
Aikawa T; Kojima M; Onishi H; Tamura R; Fukuda S; Suzuki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
J Med Virol; 1996 Aug; 49(4):274-8. PubMed ID: 8877758
[TBL] [Abstract][Full Text] [Related]
19. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.
Czaja AJ; Strettell MD; Thomson LJ; Santrach PJ; Moore SB; Donaldson PT; Williams R
Hepatology; 1997 Feb; 25(2):317-23. PubMed ID: 9021941
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen non-class II determinants for type 1 diabetes in the Finnish population.
Gombos Z; Wachowicz J; Veijola R; Akerblom HK; Simell O; Knip M; Ilonen J; Hermann R
Hum Immunol; 2006 Sep; 67(9):714-21. PubMed ID: 17002902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
